Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Energy metabolism in critically ill children treated with lipid emulsion and carnitine
2005-001762-13Phase 4Terminated
- Sponsor
- Heidelberg University Children's Hospital
- Start
- Jul 2005
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fat emulsion and levocarnitine in sepsis, asphyxia neonatorum and catabolic state, sponsored by Heidelberg University Children's Hospital. Primary endpoints: Energy balance and catabolism-related morbidity and Energy expenditure by indirect calorimetry. Started Jul 2005; status: terminated.
02
Drugs
fat emulsionlevocarnitine
03
Conditions
sepsisasphyxia neonatorumcatabolic state
Beyond the preview
Go deeper on 2005-001762-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001762-13.